Physician profile
Ahmad Nassr
NPI 1871792028
$13,891.34
in general payments reported to CMS, 2019-2025
14 companies · $2,982 in 2025
The $2,982 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2021: $310 · 2022: $631 · 2023: $3,171 · 2024: $6,593 · 2025: $2,982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,981 · Food and Beverage: $4,158 · Consulting Fee: $2,607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,981.02 |
| Food and Beverage | $4,157.83 |
| Consulting Fee | $2,607.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $3,119.67 | 2023-2025 | I-Factor Peptide Enhanced Bone Graft |
| Alphatec Spine, INC | $2,894.67 | 2024 | Other - Miscellaneous, Identiti |
| Depuy Synthes Products, INC. | $2,681.30 | 2024-2025 | Viper |
| Smaio USA Corporation | $1,019.46 | 2025 | |
| Medtronic, INC. | $949.01 | 2021-2025 | Unid_pass, Anteralign Spinal System With Titan Nanolock Surface Technology, Stealthstation S8 Platform |
| Medical Device Business Services, INC. | $891.13 | 2024-2025 | Viper, Velys, Expedium |
| Stryker Corporation | $709.53 | 2019-2024 | Everest Spinal System, Capri Corpectomy Cage System |
| Kyocera Medical Technologies, INC. | $547.49 | 2022-2025 | |
| Depuy Synthes Sales INC. | $401.14 | 2019-2024 | Fibergraft Bg Morsels, Viper, Conduit |
| Icotec Medical INC. | $258.52 | 2023-2024 | Vader Pedicle System, Icotec Blackarmor Spine System |
| Bioventus LLC | $178.60 | 2022 | |
| Foundation Medical, LLC | $137.75 | 2025 | |
| Centinel Spine, LLC | $103.07 | 2024 | Prodisc C Vivo |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmad Nassr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.